Beranda › Kanker Payudara Triple-Negatif › California › San Diego
Uji klinis Kanker Payudara Triple-Negatif di San Diego, CA
13 studi untuk Kanker Payudara Triple-Negatif mencari peserta di lokasi sekitar San Diego (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Menerima pesertaFase 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · 11 mi jauhnya
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Menerima pesertaFase 1/2
- University of San Diego Moores Cancer Center, La Jolla · 11 mi jauhnya
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Menerima pesertaStudi observasional
- University of California San Diego, La Jolla · 11 mi jauhnya
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Menerima pesertaFase 3
- Scripps Cancer Center ( Site 0052), La Jolla · 11 mi jauhnya
Intratumoral N17350 in Advanced Solid Tumors
Menerima pesertaFase 1/2
- Scripps Clinic Torrey Pines - La Jolla, San Diego
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Menerima pesertaFase 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · 11 mi jauhnya
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Menerima pesertaFase 1
- UC San Diego Moores Cancer Center, La Jolla · 11 mi jauhnya
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Menerima pesertaFase 1/2
- University of California, San Diego; Moores Cancer Center, San Diego
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Menerima pesertaFase 2
- University of California San Diego, La Jolla · 11 mi jauhnya
A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs
Menerima pesertaFase 1
- UCSD Moores Cancer Center, La Jolla · 11 mi jauhnya
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Menerima pesertaFase 1/2
- UCSD Moores Cancer Center, La Jolla · 11 mi jauhnya
A Beta-only IL-2 ImmunoTherapY Study
Menerima pesertaFase 1/2
- Sharp Memorial Hospital, San Diego
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Menerima pesertaFase 1
- UC San Diego Moores Cancer Center, La Jolla · 11 mi jauhnya
Uji klinis Kanker Payudara Triple-Negatif di kota lain
- Houston, TX42 studi
- New York City, NY31 studi
- Nashville, TN28 studi
- Los Angeles, CA27 studi
- Boston, MA26 studi
- San Antonio, TX23 studi
- St. Louis, MO21 studi
- Arlington, VA20 studi
- Atlanta, GA20 studi
- Dallas, TX18 studi
- Chicago, IL16 studi
- Columbus, OH16 studi
Studi lain di San Diego
- Kanker Paru Non-Sel Kecil48 studi
- Kanker Payudara41 studi
- Kanker (semua jenis)32 studi
- Kanker Prostat31 studi
- Kanker Metastatik30 studi
- Kanker Kolorektal25 studi
- Kanker Ovarium24 studi
- Kanker Pankreas24 studi
- Kanker Paru23 studi
- Obesitas23 studi
- Gagal Jantung23 studi
- Depresi21 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.